FORMULIERUNGEN AUS BENDAMUSTIN

Patent europeic · EP2528602 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2528602
Numer da la dumonda
EP11737745
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Mantegnì en furma midada
Annunzià
28-01-2011
Publitgà
05-12-2012
Concedì
05-10-2016
La protecziun finescha il pli tard
27-01-2031
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61K 31/415 (2006.01)
A61K 47/10 (2006.01)
A61K 47/20 (2006.01)
A61K 9/08 (2006.01)
Prioritad
US 299100 P 28.01.2010
Dumonda PCT
PCT/US2011/022958 28.01.2011
Publicaziun PCT
WO2011/094565 04.08.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-02-2026

    Midada

    Published in Swissreg on 01.02.2026

  2. 01-02-2025

    Midada

    Published in Swissreg on 01.02.2025

  3. 01-02-2024

    Midada

    Published in Swissreg on 01.02.2024

  4. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  5. 15-01-2020

    Midada

    Published in Swissreg on 15.01.2020

  6. 05-10-2016

    Concedì

    Published in Swissreg on 05.10.2016

Partidas

Possessur

Eagle Pharmaceuticals, Inc.

50 Tice Boulevard, Woodcliff Lake, NJ 07677, US

Inventur

PALEPU, Nagesh R.

Southampton, Pennsylvania 18966, US

BUXTON, Philip Christopher

Great Dunmow Essex CM6 2PB, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.